Journal article
Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka
To facilitate introduction of live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV) into the National Immunization Programme of Sri Lanka, we evaluated the safety and immunogenicity of co-administration of LJEV and measles vaccine at 9 months of age. Serum immune responses were evaluated post-vaccination on days 28, 180, and 365 using JE neutralization test and anti-measles IgG ELISA.
Authors
Languages
- English
Publication year
2014
Journal
Vaccine
Volume
37
Type
Journal article
Categories
- Service delivery
Diseases
- Japanese encephalitis
Countries
- Sri Lanka
Tags
- AEFI
WHO Regions
- South-East Asia Region